2009
DOI: 10.1002/pdi.1371
|View full text |Cite
|
Sign up to set email alerts
|

Quality of diabetes care in India, China, Brazil, Mexico and Russia

Abstract: Employing US national standards, baseline data for type 2 diabetes were collected in India, China, Brazil, Mexico and Russia prior to Staged Diabetes Management implementation. In all, 5507 patients (India 2778, China 489, Brazil 1106, Mexico 925, and Russia 209) were evaluated. No site sample met the US standard for HbA1c or blood pressure. China, India and Mexico achieved criteria for LDL ≥ 130 mg/dL. Post‐programme data from Russian sites showed significant improvement in HbA1c (p < 0.00001). In Brazil a tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 21 publications
(16 reference statements)
0
1
0
Order By: Relevance
“…A multicentre study conducted in five countries, including Brazil, identified that no country has reached the standard for HbA1c or blood pressure set by the American Diabetes Association Diabetes Physician Recognition Programme [ 52 ]. In 2007, a cross-sectional multicentre study conducted in nine Latin American countries (Argentina, Brazil, Chile, Costa Rica, Ecuador, Guatemala, Mexico, Peru, and Venezuela), including a sample of 878 Brazilians aged 18 to 75 years with type 2 diabetes, showed that about 40% of participants had controlled glycosylated haemoglobin (HbA1c <7.0%) [ 51 ].…”
Section: Resultsmentioning
confidence: 99%
“…A multicentre study conducted in five countries, including Brazil, identified that no country has reached the standard for HbA1c or blood pressure set by the American Diabetes Association Diabetes Physician Recognition Programme [ 52 ]. In 2007, a cross-sectional multicentre study conducted in nine Latin American countries (Argentina, Brazil, Chile, Costa Rica, Ecuador, Guatemala, Mexico, Peru, and Venezuela), including a sample of 878 Brazilians aged 18 to 75 years with type 2 diabetes, showed that about 40% of participants had controlled glycosylated haemoglobin (HbA1c <7.0%) [ 51 ].…”
Section: Resultsmentioning
confidence: 99%